| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |